Jonathan Schwartz

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RCKT

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Medical and Gene Therapy Officer	$454,200	—	$582,734	$1,167,241	$145,344	$14,790	$2,364,309
2023	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Medical and Gene Therapy Officer	$447,433	—	$832,482	$1,667,492	$196,871	$13,566	$3,157,844
2022	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Medical and Gene Therapy Officer	$434,600	—	$894,988	$1,004,996	$189,420	$8,453	$2,532,457
2021	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Medical and Gene Therapy Officer	$410,000	—	—	$1,324,050	$136,530	$11,265	$1,881,845
2020	Rocket Pharmaceuticals, Inc. (RCKT)	M.D., SVP and Chief Medical Officer	$395,000	$213,300	—	$1,251,033	—	$11,400	$1,870,733
2019	Rocket Pharmaceuticals, Inc. (RCKT)	M.D., SVP and Chief Medical Officer	$375,000	$155,250	—	$937,261	—	$8,165	$1,475,675
2018	Rocket Pharmaceuticals, Inc. (RCKT)	M.D., SVP and Chief Medical Officer	$359,820	$157,241	—	$830,761	—	$8,854	$1,356,675

No earnings-call appearances or filed executive changes recorded yet.